Jubilant Ingrevia Ltd Analyst Rating
based on 3 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 3 analysts offering long term price targets for Jubilant Ingrevia Ltd. An average target of ₹818.33
Source: S&P Global Market Intelligence
Jubilant Ingrevia Ltd Share analysis
Jubilant Ingrevia Ltd price forecast by 3 analysts
Upside of14.93%
High
₹910
Target
₹818.33
Low
₹696
Jubilant Ingrevia Ltd target price ₹818.33, a slight upside of 14.93% compared to current price of ₹712.05. According to 3 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Jubilant Ingrevia Ltd revenue growth forecast
Expected growth rate Q1, FY2026:28.24%
Forecast
Actual
Including amortisation and stock based compensations
Jubilant Ingrevia Ltd EPS growth forecast
EPS estimate Q1, FY2026:86.27%
Forecast
Actual
Source: S&P Global Market Intelligence
Jubilant Ingrevia Ltd Performance
Day's Low
Day's High
₹708.75₹748.252 Week's Low
52 Week's High
₹409.35₹837
| Returns % | |
| 1 Month Return | -2.68 % |
| 3 Month Return | + 0.5 % |
| 1 Year Return | + 71.17 % |
| Market Stats | |
| Previous Close | ₹744.80 |
| Open | ₹745.00 |
| Volume | 1.93L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹11,863.26Cr |
Jubilant Ingrevia Ltd Key Statistics
| P/E Ratio | 64.15 |
| PEG Ratio | -12.31 |
| Market Cap | ₹11,863.26 Cr |
| P/B Ratio | 3.2 |
| EPS | 11.58 |
| Dividend Yield | 0 |
| Sector | Chemicals |
| ROE | 7.37 |
Jubilant Ingrevia Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹11,863.26 Cr | 33% | 0.65 | ₹182 Cr | ₹4,135 Cr | |
| NA | ₹9,366.00 Cr | 41.33% | 0.56 | ₹484 Cr | ₹7,929 Cr | |
| BUY | ₹16,279.96 Cr | 117.13% | 0.74 | ₹491 Cr | ₹6,419 Cr | |
| HOLD | ₹7,702.97 Cr | 84.24% | 0.75 | ₹95 Cr | ₹1,752 Cr | |
| ₹6,574.99 Cr | 18.61% | 0.54 | ₹164 Cr | ₹2,603 Cr |
About Jubilant Ingrevia Ltd
Share Price: ₹712.05 per share as on 08 Nov, 2024 04:01 PM
Market Capitalisation: ₹11,863.26Cr as of today
Revenue: ₹1,029.00Cr as on September 2024 (Q3 24)
Net Profit: ₹59.00Cr as on September 2024 (Q3 24)
Listing date: 19 Mar, 2021
Chairperson Name: Shyam S Bhartia
| Organisation | Jubilant Ingrevia Ltd |
| Headquarters | |
| Industry | Chemicals |
| E-voting on shares | Click here to vote |
Key events for Jubilant Ingrevia Ltd
SBI Securities Picks Jubilant Ingrevia as Top Stock - 05 Nov, 2024
SBI Securities has selected Jubilant Ingrevia as its Pick of the Week, citing a potential upside of 14.3%. The company expects strong growth in specialty chemicals and nutrition, with a projected revenue increase of 13.1% for FY25. Recent Q2 results showed a net profit rise of 2.6%. Analysts remain optimistic despite some risks.
Jubilant Ingrevia Maintains Hold Rating Amid Growth Prospects - 29 Oct, 2024
Prabhudas Lilladher retains a Hold rating on Jubilant Ingrevia, targeting Rs 695. The company is expected to generate significant revenue from recent capex and a new contract, though concerns about ROCE persist.
Jubilant Ingrevia Shares Decline on Q2 Profit Report - 25 Oct, 2024
Jubilant Ingrevia Ltd's shares dropped over 4% following a muted Q2 FY25 profit growth, with a consolidated PAT of ₹59 crore, reflecting only a 2.6% YoY increase. Revenue and EBITDA growth were impacted by higher logistics costs amid container shortages and shipping expenses from the Red Sea crisis.
Jubilant Ingrevia Reports Modest Growth in Q3 - 23 Oct, 2024
Jubilant Ingrevia's September 2024 net sales rose 0.23% YoY to Rs 1,005.39 crore, with net profit increasing 4.99%. Analysts maintain a HOLD rating with a target of Rs 696, citing challenges in the agrochemical segment.
Jubilant Ingrevia Reports Q2 Results Amid Leadership Change - 22 Oct, 2024
Jubilant Ingrevia announced a 12.4% YoY increase in Q2 FY25 net profit to ₹59 crore, with revenue rising 2.5% to ₹1,045.2 crore. However, shares fell over 4% post-announcement. Additionally, Co-CEO Chandan Singh Sengar will retire on October 31, 2024, after 36 years with the company.
Jubilant Ingrevia Joins WEF's Global Lighthouse Network - 08 Oct, 2024
Jubilant Ingrevia's facility in Gujarat has joined the World Economic Forum's Global Lighthouse Network, utilizing AI technologies to improve manufacturing efficiency and reduce emissions. The company aims to further enhance digital interventions across its plants.
Insights on Jubilant Ingrevia Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 1.03K Cr → 1.05K Cr (in ₹), with an average increase of 2.1% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, 29.25 Cr → 59.0 Cr (in ₹), with an average increase of 28.7% per quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 10.56% to 12.72% in Sep 2024 quarter
- POSITIVE IMPACT
Price Rise
In the last 6 months, JUBLINGREA stock has moved up by 41.0%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 6.55% to 7.22% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 1 year, PCBL Ltd has given 95.7% return, outperforming this stock by 24.5%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 51.47% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 3 years, PCBL Ltd has given 267.4% return, outperforming this stock by 259.8%
NEGATIVE IMPACTRetail Holding Down
Retail Investor have decreased holdings from 27.08% to 25.07% in Sep 2024 quarter
Jubilant Ingrevia Ltd Financials
Index Inclusions
Jubilant Ingrevia Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 51.47% | 0.00 | |
| Foreign Institutions | 7.22% | 10.20 | |
| Mutual Funds | 12.72% | 20.44 | |
| Retail Investors | 25.07% | ||
| Others | 3.52% |
Jubilant Ingrevia Ltd Key Indicators
Jubilant Ingrevia Ltd Valuation
Jubilant Ingrevia Ltd in the last 5 years
Lowest (13.64x)
March 8, 2022
Industry (62.41x)
November 8, 2024
Today (64.15x)
November 8, 2024
Highest (73.72x)
October 3, 2024
Jubilant Ingrevia Ltd Earnings and Dividends
Jubilant Ingrevia Ltd Earnings Results
Jubilant Ingrevia Ltd’s net profit jumped 2.63% since last year same period to ₹59Cr in the Q2 2024-2025. On a quarterly growth basis, Jubilant Ingrevia Ltd has generated 21.05% jump in its net profits since last 3-months.
Read More about Earnings ResultsJubilant Ingrevia Ltd Dividends May,2024
In the quarter ending March 2024, Jubilant Ingrevia Ltd has declared dividend of ₹2.50 - translating a dividend yield of 1.05%.
Read More about Dividends
Jubilant Ingrevia Ltd Technicals Summary
Bearish
Neutral
Bullish
Jubilant Ingrevia Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Jubilant Ingrevia Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Jubilant Ingrevia Ltd shares.
Jubilant Ingrevia Ltd (JUBLINGREA) share price today is ₹712.05
Jubilant Ingrevia Ltd is listed on NSE
Jubilant Ingrevia Ltd is listed on BSE
- Today’s highest price of Jubilant Ingrevia Ltd is ₹748.2.
- Today’s lowest price of Jubilant Ingrevia Ltd is ₹708.75.
PE Ratio of Jubilant Ingrevia Ltd is 64.15
PE ratio = Jubilant Ingrevia Ltd Market price per share / Jubilant Ingrevia Ltd Earnings per share
Today’s traded volume of Jubilant Ingrevia Ltd(JUBLINGREA) is 1.93L.
Today’s market capitalisation of Jubilant Ingrevia Ltd(JUBLINGREA) is ₹11863.26Cr.
| Jubilant Ingrevia Ltd(JUBLINGREA | Price |
|---|---|
52 Week High | ₹837 |
52 Week Low | ₹409.35 |
Jubilant Ingrevia Ltd(JUBLINGREA) share price is ₹712.05. It is down -14.93% from its 52 Week High price of ₹837
Jubilant Ingrevia Ltd(JUBLINGREA) share price is ₹712.05. It is up 73.95% from its 52 Week Low price of ₹409.35
| Jubilant Ingrevia Ltd(JUBLINGREA | Returns |
|---|---|
1 Day Returns | -32.75% |
1 Month Returns | -2.68% |
3 Month Returns | 0.5% |
1 Year Returns | 71.17% |